Skip to main content

Advertisement

Table 1 Characteristics of HIV infected patients using ART with gender category at Hawassa, Southern Ethiopia

From: Influences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia

Variables Males (No = 68) Females (No = 117)
Age (years), median (IQR) 35 (28.2–40.0) 30 (25–35)
 <25 8 (11.8) 32 (27.4)
 26–35 27 (39.7) 61 (52.1)
 36–45 26 (38.2) 21 (17.9)
 ≥46 7 (10.3) 3 (2.6)
Marital status
 Single  15 (22.0) 24 (20.5)
 Married 38 (55.9) 54 (46.1)
 Divorced 7 (10.3) 12 (10.2)
 Widowed 8 (11.7) 27 (23.1)
Work status
 Unemployed 6 (8.8) 14 (11.9)
 Government 16 (23.5) 14 (11.9)
 Private 43 (63.2) 53 (25.6)
 Student 3 (4.4) 6 (5.1)
 A housewife 30 (29.0)
Physical exercise
 Sedentary 25 (36.7) 57 (48.7)
 Moderate 38 (55.9) 59 (50.4)
 Vigorous 5 (7.3) 1 (0.8)
BMI (kg/m2) 22.2 (3.2) 22.2 (3.7)
 <18.5 4 (5.9) 21 (17.9)
 18.5–24.9 50 (73.5) 75 (64.1)
 ≥25 14 (20.6) 21 (17.9)
CD4, cells/µl, median (IQR) 340 (200–486) 433 (326–572)
 <200 14 (20.6) 10 (8.5)
 200–400 25 (36.7) 32 (27.4)
 ≥400 29 (42.7) 75 (64.1)
WHO clinical stage
 I 21 (30.9) 37 (31.6)
 II 13 (19.1) 21 (17.9)
 III 29 (42.6) 48 (41.0)
 IV 5 (7.3) 11 (9.4)
NRTIs
 AZT 21 (30.9) 52 (44.4)
 TDF 27 (39.7) 32 (27.3)
 d4T 20 (29.4) 33 (28.2)
NNRTIs
 EFV 46 (67.6) 63 (53.8)
 NVP 22 (32.3) 54 (46.1)
 ART duration (months) 41.4 (19.4) 45.1 (21.5)
  1. Values are the number (percent) for variables unless otherwise indicated
  2. WHO world health organization, NRTI nucleoside reverse transcriptase inhibitor, NNRTI non nucleoside reverse transcriptase inhibitor, BMI body mass index, ART antiretroviral therapy, AZT Zidovudine, EFV Efavirenz, NVP Nevirapine, IQR interquartile range